ASMB
Price:
$24.44
Market Cap:
$388.42M
Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features ABI-H3733, which has finished Phase 1a clinical studies, and ABI-4334, currently in pre-clinical assessment for HBV treatment. Assembly Biosciences has forged collaborative partnerships, including agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation, as well as with Antios Therapeutics, Inc....[Read more]
Industry
Biotechnology
IPO Date
2010-12-17
Stock Exchange
NASDAQ
Ticker
ASMB
According to Assembly Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.65. This represents a change of 48.20% compared to the average of 4.48 of the last 4 quarters.
The mean historical Current Ratio of Assembly Biosciences, Inc. over the last ten years is 7.60. The current 6.65 Current Ratio has changed 8.64% with respect to the historical average. Over the past ten years (40 quarters), ASMB's Current Ratio was at its highest in in the September 2018 quarter at 16.42. The Current Ratio was at its lowest in in the June 2025 quarter at 1.64.
Average
7.60
Median
8.32
Minimum
2.42
Maximum
12.05
Discovering the peaks and valleys of Assembly Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 115.97%
Maximum Annual Current Ratio = 12.05
Minimum Annual Increase = -62.55%
Minimum Annual Current Ratio = 2.42
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 5.22 | 115.97% |
| 2024 | 2.42 | -29.16% |
| 2023 | 3.41 | -42.68% |
| 2022 | 5.95 | -37.98% |
| 2021 | 9.59 | 4.42% |
| 2020 | 9.19 | -20.59% |
| 2019 | 11.57 | -3.94% |
| 2018 | 12.05 | 32.00% |
| 2017 | 9.13 | 21.29% |
| 2016 | 7.52 | -62.55% |
The current Current Ratio of Assembly Biosciences, Inc. (ASMB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
3.68
5-year avg
5.32
10-year avg
7.60
Assembly Biosciences, Inc.’s Current Ratio is less than Zura Bio Limited (19.33), greater than Foghorn Therapeutics Inc. (2.92), less than Immuneering Corporation (32.45), less than Sagimet Biosciences Inc. (20.34), greater than Enanta Pharmaceuticals, Inc. (3.84), less than Aardvark Therapeutics, Inc. Common Stock (8.06), less than Nautilus Biotechnology, Inc. (11.85), greater than Arcturus Therapeutics Holdings Inc. (6.31), greater than Pyxis Oncology, Inc. (2.76), greater than Tenaya Therapeutics, Inc. (5.75),
| Company | Current Ratio | Market cap |
|---|---|---|
| 19.33 | $243.83M | |
| 2.92 | $243.66M | |
| 32.45 | $160.09M | |
| 20.34 | $217.65M | |
| 3.84 | $293.92M | |
| 8.06 | $85.74M | |
| 11.85 | $289.74M | |
| 6.31 | $214.03M | |
| 2.76 | $128.61M | |
| 5.75 | $121.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assembly Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Assembly Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Assembly Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Assembly Biosciences, Inc. (ASMB)?
What is the highest Current Ratio for Assembly Biosciences, Inc. (ASMB)?
What is the 3-year average Current Ratio for Assembly Biosciences, Inc. (ASMB)?
What is the 5-year average Current Ratio for Assembly Biosciences, Inc. (ASMB)?
How does the current Current Ratio for Assembly Biosciences, Inc. (ASMB) compare to its historical average?